Cutia Therapeutics
HKEX:2487

Watchlist Manager

Cutia Therapeutics

HKEX:2487

Watchlist

Discount Rate

Price: 14.06 HKD -0.28% Market Closed

Market Cap: 4.3B HKD

Have any thoughts about
Cutia Therapeutics?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 14.06 HKD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

Alert

Cutia Therapeutics

14.06

-0.04 (-0.28%)

52 Week Range	5.7 22.8
Price Target

We'll email you a reminder when the closing price reaches HKD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Cutia Therapeutics

What unique competitive advantages
does Cutia Therapeutics hold over its rivals?

What risks and challenges
does Cutia Therapeutics face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Cutia Therapeutics.

What unique competitive advantages
does Cutia Therapeutics hold over its rivals?

What risks and challenges
does Cutia Therapeutics face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cutia Therapeutics.

Provide P/S
for Cutia Therapeutics.

Provide P/E
for Cutia Therapeutics.

Provide P/OCF
for Cutia Therapeutics.

Provide P/FCFE
for Cutia Therapeutics.

Provide P/B
for Cutia Therapeutics.

Provide EV/S
for Cutia Therapeutics.

Provide EV/GP
for Cutia Therapeutics.

Provide EV/EBITDA
for Cutia Therapeutics.

Provide EV/EBIT
for Cutia Therapeutics.

Provide EV/OCF
for Cutia Therapeutics.

Provide EV/FCFF
for Cutia Therapeutics.

Provide EV/IC
for Cutia Therapeutics.

Show me price targets
for Cutia Therapeutics made by professional analysts.

What are the Revenue projections
for Cutia Therapeutics?

How accurate were the past Revenue estimates
for Cutia Therapeutics?

What are the Net Income projections
for Cutia Therapeutics?

How accurate were the past Net Income estimates
for Cutia Therapeutics?

What are the EPS projections
for Cutia Therapeutics?

How accurate were the past EPS estimates
for Cutia Therapeutics?

What are the EBIT projections
for Cutia Therapeutics?

How accurate were the past EBIT estimates
for Cutia Therapeutics?

Compare the revenue forecasts
for Cutia Therapeutics with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cutia Therapeutics and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cutia Therapeutics against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cutia Therapeutics compared to its peers.

Compare the P/E ratios
of Cutia Therapeutics against its peers.

Discuss the investment returns and shareholder value creation
comparing Cutia Therapeutics with its peers.

Analyze the financial leverage
of Cutia Therapeutics compared to its main competitors.

Show all profitability ratios
for Cutia Therapeutics.

Provide ROE
for Cutia Therapeutics.

Provide ROA
for Cutia Therapeutics.

Provide ROIC
for Cutia Therapeutics.

Provide ROCE
for Cutia Therapeutics.

Provide Gross Margin
for Cutia Therapeutics.

Provide Operating Margin
for Cutia Therapeutics.

Provide Net Margin
for Cutia Therapeutics.

Provide FCF Margin
for Cutia Therapeutics.

Show all solvency ratios
for Cutia Therapeutics.

Provide D/E Ratio
for Cutia Therapeutics.

Provide D/A Ratio
for Cutia Therapeutics.

Provide Interest Coverage Ratio
for Cutia Therapeutics.

Provide Altman Z-Score Ratio
for Cutia Therapeutics.

Provide Quick Ratio
for Cutia Therapeutics.

Provide Current Ratio
for Cutia Therapeutics.

Provide Cash Ratio
for Cutia Therapeutics.

What is the historical Revenue growth
over the last 5 years for Cutia Therapeutics?

What is the historical Net Income growth
over the last 5 years for Cutia Therapeutics?

What is the current Free Cash Flow
of Cutia Therapeutics?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cutia Therapeutics.

Financials Section:

Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

1.5B

-12%

Assets

Jun 30, 2024	1.5B
Dec 31, 2023	1.7B
Jun 30, 2023	1.8B

319.4m

-11%

Liabilities

Jun 30, 2024	319.4m
Dec 31, 2023	357.8m
Jun 30, 2023	172.4m

1.2B

-12%

Equity

Jun 30, 2024	1.2B
Dec 31, 2023	1.3B
Jun 30, 2023	1.6B

Balance Sheet Decomposition
Cutia Therapeutics

Current Assets	1.2B
Cash & Short-Term Investments	1B
Receivables	54.6m
Other Current Assets	116.4m
Non-Current Assets	297.7m
PP&E	223.4m
Intangibles	8.2m
Other Non-Current Assets	66.1m

Current Liabilities	237.8m
Accounts Payable	55.4m
Other Current Liabilities	182.4m
Non-Current Liabilities	81.7m
Long-Term Debt	81.7m

Balance Sheet
Cutia Therapeutics

Rotate your device to view
Balance Sheet

Currency: CNY

	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	203	466	473
Cash Equivalents	203	466	473
Short-Term Investments	1 175	611	800
Total Receivables	1	4	77
Accounts Receivables	0	0	62
Other Receivables	1	4	15
Inventory	2	20	45
Other Current Assets	21	45	21
Total Current Assets	1 402	1 145	1 416
PP&E Net	51	229	231
PP&E Gross	51	229	231
Accumulated Depreciation	6	17	48
Intangible Assets	0	1	8
Note Receivable	14	37	42
Other Long-Term Assets	28	35	10
Total Assets	1 495 N/A	1 447 -3%	1 707 +18%
Liabilities
Accounts Payable	0	0	134
Accrued Liabilities	13	38	49
Short-Term Debt	0	0	89
Current Portion of Long-Term Debt	4	9	51
Other Current Liabilities	2	31	45
Total Current Liabilities	19	77	255
Long-Term Debt	2 266	2 615	103
Other Liabilities	0	0	0
Total Liabilities	2 285 N/A	2 693 +18%	358 -87%
Equity
Common Stock	0	0	0
Retained Earnings	1 050	1 506	3 337
Additional Paid In Capital	259	259	4 686
Total Equity	791 N/A	1 246 -58%	1 349 N/A
Total Liabilities & Equity	1 495 N/A	1 447 -3%	1 707 +18%
Shares Outstanding
Common Shares Outstanding	304	304	304

Switch to:

Income Statement Balance Sheet Cash Flow Statement

Switch to:

Income Statement Balance Sheet Cash Flow Statement

Cutia Therapeutics
HKEX:2487

Balance Sheet

Balance Sheet Decomposition
Cutia Therapeutics

Balance Sheet
Cutia Therapeutics

See Also

Company

Help

Tools

Stocks

Cutia Therapeutics HKEX:2487

Balance Sheet

Balance Sheet Decomposition Cutia Therapeutics

Balance Sheet Cutia Therapeutics

See Also

Company

Help

Tools

Stocks

Cutia Therapeutics
HKEX:2487

Balance Sheet Decomposition
Cutia Therapeutics

Balance Sheet
Cutia Therapeutics